EDT Pharma Holdings and PAR Pharmaceutical filed suit against TWI Pharmaceuticals over a patent related to nanoparticulate megestrol formulations. 9/2, Northern District of Illinois, 1:2011cv06134.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
